Study guide

11.2 PTAB Appeal Decisions & Judicial Review

USPTO Registration Examination Patent Bar

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview, Registration & MPEP Structure

1.1 Patent Bar Exam Format & Administration 1.2 Practitioner Qualifications & Eligibility 1.3 MPEP Structure & Effective Search Strategies

2 Chapter 2: Subject Matter Eligibility & Utility (35 U.S.C. § 101)

2.1 Patent-Eligible Subject Matter & Statutory Categories 2.2 Judicial Exceptions & the Alice/Mayo Framework 2.3 Utility Requirements & USPTO Utility Guidelines

3 Chapter 3: Novelty & Prior Art Under the AIA (35 U.S.C. § 102)

3.1 First-Inventor-to-File (FITF) & Effective Filing Dates 3.2 The One-Year Inventor Grace Period & Exceptions 3.3 Prior Art Types & Public Availability Standards

4 Chapter 4: Nonobviousness Analysis (35 U.S.C. § 103)

4.1 The Graham Factors & KSR Obviousness Framework 4.2 Combining Prior Art References & Motivation to Combine 4.3 Overcoming § 103 Rejections & Rule 132 Affidavits

5 Chapter 5: Specification & Disclosure Requirements (35 U.S.C. § 112(a))

5.1 Written Description Requirement 5.2 Enablement Requirement & Wands Factors 5.3 Best Mode Requirement & Current Post-AIA Status

6 Chapter 6: Claim Requirements & Definiteness (35 U.S.C. § 112(b)-(f))

6.1 Definiteness & Claim Precision 6.2 Independent & Dependent Claim Construction 6.3 Special Claim Formats: Means-Plus-Function & Markush Claims

7 Chapter 7: Application Types & Filing Procedures (MPEP Chapter 600)

7.1 Provisional Patent Applications 7.2 Nonprovisional Application Parts & Formalities 7.3 Inventor Oaths, Declarations & Assignments

8 Chapter 8: Duty of Disclosure & Information Disclosure Statements

8.1 Duty of Candor & Good Faith 8.2 Information Disclosure Statements (IDS) Requirements 8.3 Correcting Non-Disclosure & Duty Compliance

9 Chapter 9: Patent Prosecution & Office Action Responses (MPEP Chapter 700)

9.1 Initial Examination & Non-Final Office Actions 9.2 Statutory Deadlines & Extension of Time 9.3 Final Office Actions & Post-Final Practice

10 Chapter 10: Continuing Applications & Copendency

10.1 Continuation Applications 10.2 Divisional Applications 10.3 Continuation-in-Part (CIP) Applications & Priority Allocation

11 Chapter 11: Appeals & Interferences/Derivation (MPEP Chapter 1200 & 2300)

11.1 Ex Parte Appeals to the PTAB 11.2 PTAB Appeal Decisions & Judicial Review 11.3 Derivation Proceedings Under the AIA

12 Chapter 12: Post-Grant Proceedings & Corrections (MPEP Chapters 1400 & 2200)

12.1 Reissue Applications & Certificates of Correction 12.2 Ex Parte Reexamination & Supplemental Examination 12.3 Inter Partes Review (IPR) & Post-Grant Review (PGR)

13 Chapter 13: Patent Term, Maintenance Fees & Ownership

13.1 Patent Term Calculation & Patent Term Adjustment (PTA) 13.2 Maintenance Fees & Expiration 13.3 Inventorship, Ownership & Assignment Recordation 13.4 Patent Term Extension Under 35 U.S.C. § 156

14 Chapter 14: International Patent Practice & PCT (MPEP Chapter 1800)

14.1 The Patent Cooperation Treaty (PCT) Overview 14.2 PCT International Phase & Chapter I / Chapter II 14.3 National Phase Entry Under 35 U.S.C. § 371

15 Chapter 15: Special Patent Categories & Professional Conduct

15.1 Design Patents & Plant Patents 15.2 USPTO Rules of Professional Conduct 15.3 Patent Bar Exam Strategy & Open-Book Navigation Tips

16 Chapter 16: Security, Access, Representation & Filing Mechanics

16.1 Secrecy, Application Access & Foreign Filing Licenses 16.2 Representation, Power of Attorney & Correspondence 16.3 Filing Receipt, Certificates of Transmission & Signatures

17 Chapter 17: Restriction, Publication, Allowance & Office Authority

17.1 Restriction, Election, Rejoinder & Double Patenting 17.2 Publication, Preissuance Submissions & Protests 17.3 Allowance, Issue Fee & Withdrawal from Issue 17.4 Examiner Interviews, Petitions & Office Authority

18 Chapter 18: Biotechnology Disclosure & Patent Prosecution Highway

18.1 Biological Deposits & Sequence Listings 18.2 Global/IP5 Patent Prosecution Highway

19 Chapter 19: AIA Trial Practice Under the Consolidated Guide

19.1 AIA Trial Petitions, Preliminary Response & Institution 19.2 AIA Trial Discovery, Motions, Hearing & Final Decision

11.2 PTAB Appeal Decisions & Judicial Review

Key Takeaways Explain This Topic AI

The PTAB panel can affirm, reverse, remand, or issue a new ground of rejection under 37 C.F.R. § 41.50(b).

When the Board issues a new ground of rejection under 37 C.F.R. § 41.50(b), the applicant has 2 months to either reopen prosecution before the examiner or request rehearing by the Board.

A Request for Rehearing under 37 C.F.R. § 41.52 must be filed within 2 months of the PTAB decision and must specifically point out points of law or fact misapprehended or overlooked by the Board.

Judicial review of a final PTAB decision offers two mutually exclusive pathways: direct appeal to the U.S. Court of Appeals for the Federal Circuit under 35 U.S.C. § 141 OR a civil action against the USPTO Director in the U.S. District Court for the Eastern District of Virginia under 35 U.S.C. § 145.

A § 145 civil action permits the applicant to introduce new evidence into the record, unlike a § 141 Federal Circuit appeal which is strictly limited to the administrative record before the USPTO.

Last updated: August 2026

11.2 PTAB Appeal Decisions & Judicial Review

Following the submission of briefs and any oral hearing, a three-member panel of Administrative Patent Judges (APJs) on the Patent Trial and Appeal Board (PTAB) evaluates the appeal and issues a decision. The decision of the Board, subsequent administrative remedies, and options for external judicial review are governed by 37 C.F.R. § 41.50 – § 41.54 , MPEP Chapter 1200 , and 35 U.S.C. §§ 141 and 145 . Mastering the distinctions between Board outcomes and the procedural bifurcations of judicial review is essential for patent practitioners.

PTAB Board Decision Outcomes (37 C.F.R. § 41.50)

The Board has wide statutory authority in deciding an ex parte appeal. Under 37 C.F.R. § 41.50(a) , the Board may:

Affirm: Agree with the examiner's rejection of one or more claims (in whole or in part).

Reverse: Overturn the examiner's rejection of one or more claims.

Remand: Send the application back to the primary examiner for further consideration or search, without issuing a final ruling on patentability.

Issue a New Ground of Rejection: Explicitly reject claims on grounds not previously relied upon by the examiner.

New Ground of Rejection by the Board (37 C.F.R. § 41.50(b))

If the Board identifies a ground of rejection not advanced in the Examiner's Answer, it may issue a new ground of rejection under 37 C.F.R. § 41.50(b) . Such a decision is explicitly deemed a non-final decision for purposes of judicial review, and triggers statutory safeguards for the applicant.

Applicant's Two Exclusive Options (2-Month Window):

Within 2 months from the date of the Board's decision, the applicant must choose one of the following two mutually exclusive courses of action:

Option 1: Reopen Prosecution Before the Examiner (§ 41.50(b)(1))

The applicant submits an amendment of the rejected claims or new evidence (e.g., Rule 132 affidavits).

Prosecution is reopened before the primary examiner. The examiner is bound by the Board's rejection but must consider the applicant's new amendments and evidence.

Option 2: Request Rehearing by the Board (§ 41.50(b)(2))

The applicant files a Request for Rehearing directly before the Board, arguing that the Board erred in its new ground of rejection based strictly on the existing record.

No new evidence or claim amendments may be introduced under this option.

Note: If the applicant takes no action within the 2-month period, the Board's § 41.50(b) decision becomes a final decision affirming the rejection, resulting in abandonment of the rejected claims.

Board Recommendations for Allowance or Rejection (37 C.F.R. § 41.50(c))

Under 37 C.F.R. § 41.50(c) , the Board may include in its decision a recommendation that a claim allowed by the examiner should be rejected, or that a rejected claim may be allowed if amended in a specified manner.

A recommendation for allowance is non-binding on the examiner but carries high persuasive weight.

If the examiner follows a Board recommendation to reject an allowed claim, prosecution is reopened as to that claim.

Request for Rehearing Before the PTAB (37 C.F.R. § 41.52)

An applicant dissatisfied with a final decision of the Board may file a Request for Rehearing under 37 C.F.R. § 41.52 .

Procedural & Content Requirements:

Timing: Must be filed within 2 months from the date of the Board's decision.

Extensions: Non-extendable under 37 C.F.R. § 1.136(a). Extensions require a showing of cause under § 1.136(b).

Strict Scope: The request must state with particularity the points of law or fact that the Board misapprehended or overlooked.

No New Arguments or Evidence: The rehearing petition cannot present new arguments or new evidence that were not part of the original appeal record, unless justified by good cause.

Board Action: The Board may grant or deny the request, or modify its original decision. Filing a timely Request for Rehearing resets the clock for seeking judicial review.

Judicial Review Pathways: 35 U.S.C. § 141 vs. 35 U.S.C. § 145

If the applicant receives an adverse final PTAB decision (or after a Request for Rehearing is decided), the applicant may seek external judicial review. Congress provided two mutually exclusive pathways for judicial review under the Patent Act. Adverse Final PTAB Decision

  • │
  • ┌───────────────────────┴───────────────────────┐
  • ▼ ▼

Direct Appeal to Federal Circuit Civil Action in E.D. Va.

  • (35 U.S.C. § 141) (35 U.S.C. § 145)
  • Closed administrative record • De novo evidentiary trial
  • Substantial evidence standard • May introduce NEW evidence
  • No liability for USPTO legal expenses • Must pay ALL USPTO expenses
  • Pathway 1: Direct Appeal to the Federal Circuit (35 U.S.C. § 141)

Forum: United States Court of Appeals for the Federal Circuit (CAFC).

Deadline: Must file a Notice of Appeal within 63 days of the PTAB final decision or decision on rehearing (37 C.F.R. § 90.3).

Evidentiary Record: Strictly restricted to the closed administrative record established at the USPTO. No new evidence or live witness testimony may be introduced.

Standard of Review:

Legal questions (e.g., claim construction, statutory interpretation): Reviewed de novo .

Factual determinations (e.g., prior art disclosures, level of ordinary skill): Reviewed under the deferential substantial evidence standard pursuant to the Administrative Procedure Act (APA).

Expenses: Each party bears its own litigation costs.

Pathway 2: Civil Action Against the USPTO Director (35 U.S.C. § 145)

Forum: United States District Court for the Eastern District of Virginia (E.D. Va.).

Deadline: Must commence civil action within 63 days of the PTAB final decision or decision on rehearing (37 C.F.R. § 90.3).

De Novo Evidentiary Trial: The applicant is permitted to introduce new documentary evidence and live expert testimony that was not presented to the USPTO (established in Kappos v. Hyatt , 566 U.S. 431 (2012)).

Standard of Review: If new evidence is presented on a factual issue, the district court considers that issue de novo . If no new evidence is presented, APA substantial evidence deferential review applies.

Mandatory Expense Shift: Under 35 U.S.C. § 145, the applicant is statutorily required to pay all expenses of the proceeding incurred by the USPTO (including USPTO attorney/paralegal time and expert witness fees), regardless of whether the applicant wins or loses.

Comparison of Judicial Review Pathways

  • Feature 35 U.S.C. § 141 Appeal 35 U.S.C. § 145 Civil Action
  • Court Forum U.S. Court of Appeals for Federal Circuit U.S. District Court for Eastern District of Virginia
  • Filing Window 63 days from final PTAB decision 63 days from final PTAB decision
  • New Evidence Permitted? NO (Closed administrative record) YES (Live witnesses, expert affidavits)
  • Standard for Fact Review Substantial evidence (APA deferential) De novo (if new evidence introduced)
  • USPTO Expense Liability Ordinary court costs Applicant pays ALL USPTO expenses win or lose
  • Subsequent Appeal Directly to U.S. Supreme Court Appeal to Federal Circuit, then Supreme Court

Loading diagram... Post-PTAB Decision Options & Judicial Review Paths